These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 38855953)

  • 1. Development of Ryanodine Receptor (RyR) Inhibitors for Skeletal Muscle and Heart Diseases.
    Matsukawa H; Murayama T
    Juntendo Iji Zasshi; 2023; 69(3):180-187. PubMed ID: 38855953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assays for Modulators of Ryanodine Receptor (RyR)/Ca
    Murayama T; Kurebayashi N
    Curr Protoc Pharmacol; 2019 Dec; 87(1):e71. PubMed ID: 31834676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug development for the treatment of RyR1-related skeletal muscle diseases.
    Murayama T; Kurebayashi N; Ishida R; Kagechika H
    Curr Opin Pharmacol; 2023 Apr; 69():102356. PubMed ID: 36842386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac ryanodine receptor N-terminal region biosensors identify novel inhibitors via FRET-based high-throughput screening.
    Zhang J; Singh DP; Ko CY; Nikolaienko R; Wong King Yuen SM; Schwarz JA; Treinen LM; Tung CC; Rožman K; Svensson B; Aldrich CC; Zima AV; Thomas DD; Bers DM; Launikonis BS; Van Petegem F; Cornea RL
    J Biol Chem; 2022 Jan; 298(1):101412. PubMed ID: 34793835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient High-Throughput Screening by Endoplasmic Reticulum Ca
    Murayama T; Kurebayashi N; Ishigami-Yuasa M; Mori S; Suzuki Y; Akima R; Ogawa H; Suzuki J; Kanemaru K; Oyamada H; Kiuchi Y; Iino M; Kagechika H; Sakurai T
    Mol Pharmacol; 2018 Jul; 94(1):722-730. PubMed ID: 29674523
    [